222 related articles for article (PubMed ID: 16914206)
21. [Body dysmorphic disorder. Epidemiology, clinical symptoms, classification and differential treatment indications: an overview].
Driesch G; Burgmer M; Heuft G
Nervenarzt; 2004 Sep; 75(9):917-29; quiz 930-1. PubMed ID: 15316620
[TBL] [Abstract][Full Text] [Related]
22. [Personality disorders 4/4].
Narfin R
Rev Infirm; 2011 Feb; (168):47-8. PubMed ID: 21341452
[No Abstract] [Full Text] [Related]
23. Categorical and dimensional stability of comorbid personality disorder symptoms in DSM-IV major depressive disorder: a prospective study.
Melartin TK; Haukka J; Rytsälä HJ; Jylhä PJ; Isometsä ET
J Clin Psychiatry; 2010 Mar; 71(3):287-95. PubMed ID: 20079331
[TBL] [Abstract][Full Text] [Related]
24. Insight in body dysmorphic disorder with and without comorbid obsessive-compulsive disorder.
Marazziti D; Giannotti D; Catena MC; Carlini M; Dell'Osso B; Presta S; Pfanner C; Mungai F; Dell'Osso L
CNS Spectr; 2006 Jul; 11(7):494-8. PubMed ID: 16816788
[TBL] [Abstract][Full Text] [Related]
25. Insight in obsessive compulsive disorder and body dysmorphic disorder.
Eisen JL; Phillips KA; Coles ME; Rasmussen SA
Compr Psychiatry; 2004; 45(1):10-5. PubMed ID: 14671731
[TBL] [Abstract][Full Text] [Related]
26. Avoidant personality disorder is a separable schizophrenia-spectrum personality disorder even when controlling for the presence of paranoid and schizotypal personality disorders The UCLA family study.
Fogelson DL; Nuechterlein KH; Asarnow RA; Payne DL; Subotnik KL; Jacobson KC; Neale MC; Kendler KS
Schizophr Res; 2007 Mar; 91(1-3):192-9. PubMed ID: 17306508
[TBL] [Abstract][Full Text] [Related]
27. Covariance of personality, neurocognition, and schizophrenia spectrum traits in the community.
Tien AY; Costa PT; Eaton WW
Schizophr Res; 1992 Jul; 7(2):149-58. PubMed ID: 1515376
[TBL] [Abstract][Full Text] [Related]
28. The schizotypal ambivalence scale as a marker of schizotypy.
Mann MC; Vaughn AG; Barrantes-Vidal N; Raulin ML; Kwapil TR
J Nerv Ment Dis; 2008 May; 196(5):399-404. PubMed ID: 18477882
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients.
Grant JE; Kim SW; Crow SJ
J Clin Psychiatry; 2001 Jul; 62(7):517-22. PubMed ID: 11488361
[TBL] [Abstract][Full Text] [Related]
30. Body dysmorphic disorder in cosmetic surgery patients.
Sarwer DB; Crerand CE; Didie ER
Facial Plast Surg; 2003 Feb; 19(1):7-18. PubMed ID: 12739178
[TBL] [Abstract][Full Text] [Related]
31. Yale-Brown Obsessive Compulsive Scale modified for Body Dysmorphic Disorder (BDD-YBOCS): Brazilian Portuguese translation, cultural adaptation and validation.
de Brito MJ; Sabino Neto M; de Oliveira MF; Cordás TA; Duarte LS; Rosella MF; Felix GA; Ferreira LM
Braz J Psychiatry; 2015; 37(4):310-6. PubMed ID: 26692429
[TBL] [Abstract][Full Text] [Related]
32. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.
Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A
J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937
[TBL] [Abstract][Full Text] [Related]
33. Depressive symptoms induce paranoid symptoms in narcissistic personalities (but not narcissistic symptoms in paranoid personalities).
Joiner TE; Petty S; Perez M; Sachs-Ericsson N; Rudd MD
Psychiatry Res; 2008 May; 159(1-2):237-44. PubMed ID: 18423618
[TBL] [Abstract][Full Text] [Related]
34. Hierarchical relationships between borderline, schizotypal, avoidant and obsessive-compulsive personality disorders.
Hopwood CJ; Morey LC; Gunderson JG; Skodol AE; Tracie Shea M; Grilo CM; McGlashan TH
Acta Psychiatr Scand; 2006 May; 113(5):430-9. PubMed ID: 16603034
[TBL] [Abstract][Full Text] [Related]
35. Predictors of remission from body dysmorphic disorder: a prospective study.
Phillips KA; Pagano ME; Menard W; Fay C; Stout RL
J Nerv Ment Dis; 2005 Aug; 193(8):564-7. PubMed ID: 16082302
[TBL] [Abstract][Full Text] [Related]
36. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
Phillips KA; Albertini RS; Rasmussen SA
Arch Gen Psychiatry; 2002 Apr; 59(4):381-8. PubMed ID: 11926939
[TBL] [Abstract][Full Text] [Related]
37. Substance use disorders in individuals with body dysmorphic disorder.
Grant JE; Menard W; Pagano ME; Fay C; Phillips KA
J Clin Psychiatry; 2005 Mar; 66(3):309-16; quiz 404-5. PubMed ID: 15766296
[TBL] [Abstract][Full Text] [Related]
38. [Preliminary comparative study of the personality disorder evaluation DIP instrument with the semi-structured SCID-II interview].
Massoubre C; Bonnefond H; Grosselin A; Nelva A; Pellet J; Lang F
Encephale; 2009 Dec; 35(6):544-53. PubMed ID: 20004285
[TBL] [Abstract][Full Text] [Related]
39. Clinical and subclinical body dysmorphic disorder.
Altamura C; Paluello MM; Mundo E; Medda S; Mannu P
Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):105-8. PubMed ID: 11697569
[TBL] [Abstract][Full Text] [Related]
40. The Prevalence of Body Dysmorphic Disorder in Patients Undergoing Cosmetic Surgery: a Systematic Review.
Panayi A
Psychiatr Danub; 2015 Sep; 27 Suppl 1():S438-44. PubMed ID: 26417812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
